Timolol 0.5% versus Latanoprost 0.005% as A Single Hypotensive Drug in Glaucoma Patients: A 2-year Follow-up
Comparison of Efficacy and Safety of Latanoprost versus Fixed Combination of Tafluprost and Timolol in Patients with Primary Open-Angle Glaucoma
Demographics, Clinical Presentation, Staging, Management and Outcome of Urinary Bladder Cancer in Qassim Region
Demographics, Clinical Presentation, Management and Outcome of Patients with Urethral Stricture in Qassim Region
Expression of Androgen, Estrogen, and Progesterone Receptors in the Skin of Patients with Severe Acne and the Assessment of Their Predictive Potential Using Artificial Intelligence Methods
Expression of Long Non-Coding RNA H19 and miR-675 in Patients with Colorectal Cancer and Ulcerative Colitis